Clinical Report: Non-linear Association of Creatinine Levels with Adverse Events Post-PCI

Overview

This study identifies a J-shaped relationship between creatinine levels and the risk of major adverse events (MACE) in patients post-percutaneous coronary intervention (PCI). An inflection point at 110 μmol/L was established, indicating increased risk for patients with lower creatinine levels.

Background

Acute myocardial infarction (AMI) is a critical condition with significant implications for patient health and healthcare systems. Following PCI, patients remain at risk for major adverse cardiovascular events (MACE), necessitating effective risk stratification. Understanding the role of creatinine levels in predicting these outcomes can enhance clinical decision-making and patient management.

Data Highlights

Key Findings

• A total of 3,878 AMI patients were analyzed post-PCI.
• 25.7% of patients experienced adverse events post-procedure.
• A J-shaped correlation was found between creatinine levels and MACE risk.
• The inflection point for creatinine levels was identified at 110 μmol/L.
• Patients with creatinine levels below 110 μmol/L showed significant increases in MACE, NACE, and MACCE risks.

Clinical Implications

Clinicians should consider creatinine levels as a critical factor in assessing the risk of adverse events in AMI patients post-PCI. The identified threshold of 110 μmol/L can guide risk stratification and inform individualized patient management strategies.

Conclusion

The study underscores the importance of monitoring creatinine levels in AMI patients post-PCI, highlighting a specific threshold that may aid in predicting adverse outcomes. Further research is warranted to validate these findings in broader populations.

References

1. Author(s)/Org, Source, Year -- Title
2. Author(s)/Org, Source, Year -- Title
3. Author(s)/Org, Source, Year -- Title
4. Author(s)/Org, Source, Year -- Title